Abbott Laboratories has reported sales of $10.6bn for the third quarter (Q3) of 2024, as against $10.4bn in Q2 2024, with ...

On Thursday night, October 17th, Netflix will release their 3rd quarter ’24 financial results after the closing bell.

Discover the best growth stocks for the next decade. Explore top investment opportunities with high growth potential to help ...

Abbott Laboratories ABT reported third-quarter 2024 adjusted earnings per share (EPS) of $1.21, which beat the Zacks ...

Abbott Laboratories shares rose Wednesday after the drug and healthcare products maker reported better-than-expected ...

Abbott Laboratories (NYSE: ABT) reported a robust performance for the third quarter of 2024, with total worldwide sales ...

Abbott’s earnings for the third quarter (Q3) of 2024 saw global sales reach $10.6 billion, a strong performance driven by the ...

Adjusted EPS was $1.21, topping the estimate of $1.20 ... Sales growth was led by double-digit growth in Diabetes Care, ...

For fiscal 2024, analysts expect PFE to report an EPS of $2.66, up 44.6% from $1.84 in fiscal 2023 . Shares of PFE have ...

The company attributed the uptick to double-digit growth in Diabetes Care, Structural Heart, Heart Failure and ...